Plasma biomarker discovery sits at the heart of precision medicine, drug development, and translational research.
Collaboration supports global LRRK2 Investigative Therapeutics Exchange (LITE) to accelerate development of reliable biomarkers for Parkinson’s disease
At this year’s AACR Annual Meeting 2026 in San Diego, Biognosys Group will have a strong presence with 8 scientific posters and an immersive booth experience.
Poster presented at US HUPO 2026
Contact
Contact Form
Global Headquarters
Biognosys AG Wagistrasse 21 8952 Schlieren Switzerland
Phone: +41 44 244 50 00
US Offices Biognosys Inc 70 Bridge St, Suite 104 Newton, MA 02458 United States
Sign up and receive our latest updates
You are leaving Biognosys.com for Bruker.com.Do you want to proceed?